JONES DAY 2727 NORTH HARWOOD STREET DALLAS, TEXAS 75201 -1 51 5 MAILING ADDRESS: P.O.
refid# barELyyxp1Bj5rDXDdp8vxGdk461 pages
Case 5:07-cv-0Q 83-WRF w Document 25 /ljlc Filed ll/2fi/07 Page 1 of 44 FILED UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS UNITED STATES OF AMERICA, NOV 2 0 2007 CLERK, WESTER VKicr COURT it OF TEXAS and THE STATE OF OHIO PlaintifSs, and theM>^mphis Shelby County Health Department, Plainltiff--tervener, The Premcor Refining Group Inc,, and The Lima Refining Company, Defendants, ) ) ) ) ) ) ) ) ) ) ) ) ) CIVIL ACTION NO.
refid# ELgqj4E1Y8doDeo0518nwB6n148 pages
1 Mking Informition AnAMKOcnm UNION CARBIDE CORP NEW Filing Type: PROXY Description: N/A Filing Date: 10/06/99 Ticker: UK Cusip: 905581 State: CT Country: US Primary SIC: 2821 Primary Exchange: NYS Billing Cross Reference: Date Printed: 08/29/2000 This document produced using Global Access http://www.disclosure.com/dga UNION CARBIDE CORP NEW - PROXY Table of Contents Created by Disclosure Filing Date: 10/06/99 Filing Sections Tojump to section, click on hypertexted page number Document........................................................................................................................................................................ 1 Base................................................................................................................................................................................ 1 Cover Page...................................................................................................................................................................... 1 General/Summary/Introduction..................................................................................................................................... 3 Notice of Meeting...........................................................................................................................................................4 Voting Issues..................................................................................................................................................................4 Table of Contents........................................................................................................................................................... 8 Financial Statements..................................................... 84 Balance Sheet........................................................ 85 Income Statement...................................................... 86 Financial Footnotes..................................................... 91 Exhibits Exhibits.........................................................................................................................................................................92 This document produced using Global Access http://www.disclosurc.coni/dga UNION CARBIDE CORP NEW - PROXY Filing Dale: 10/06/99 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14 (a) of the Securities Exchange Act of 1934 Filed by the Registrant {X} Filed by a Party other than the Registrant { } Check the appropriate box: { } Preliminary Proxy Statement { } CONFIDENTIAL FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e) (2)) (X) Definitive Proxy Statement { } Definitive Additional Materials { } Soliciting Material Pursuant to Rule 14a-ll(c) or Rule 14a-12 Filing by: Union Carbide Corporation (Name of Each Registrant as Specified in Its Charter) (Name of Person(s) Filing Statement, if other than the Registrant) Payment of filing fee (check the appropriate box): { } No fee required. { ) Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined: (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: {X} Fee paid previously with preliminary materials. { ) Check box if any part of the fee is offset as provided in Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
refid# 4vKOK7XJmV6O04z14nROrrvgj164 pages
43 Environmental Laboratory 26H8 - 0500 - 373 3M EEnnvviirroonnmmeennttaall LaLabboorraattoor:y ARD26-0945 & Z Nos FFiinnaall RReeppoorrtt-- AAnnaalylyttiiccaall SSttuuddyy EG Single-dose Intravenous Pharmacokinetic Study ofT6246 in Rabbits Single-dose Intravenous Pharmacokinetic Study ofT-6246 in Rabbits IInn--VViivvoo SSttuuddyy RReeffeerreennccee Number: Number: HWI#6329-159 HWI#6329-159 SSttuuddyy NNuummbbeerr:: AMDT-042095.1 AMDT-042095.1 TTeesstt SSuubbssttaannccee:: FC-95 (T-6246) FC-95 ('I?
refid# mV8NVG5pD6bNYg3XOjbbbmv4271 pages
The dam apparently had problems in delivering its litter, resulting in the fetuses dying in utero, leading to its adverse clinical condition.
refid# 2qyy4rjD8KMVm8X4Q5r16o10L123 pages
The following personnel from MPI Research were associated with various phases of this interim portion of the study: Name Charles Simons John Flaherty Karen Risha Paul Connolly Chrissy Edwards Mark Ammerman Amy Sheehan Krista Gallant Nancy Saxton Brittany Kravets Title Director Analytical Lab Operations, PI Vice President Analytical Manager Director Bioanalytical Analytical Project Leader Project Lead Sample Control Analytical Group Leader Research Chemist Associate 2 Research Chemist Associate 1 Technician MPI Research, Inc.
refid# k6XrgRVYeNN4eqRZE53ZYm9n0149 pages
06/29/2004 14:56 FAX McCarter & English llp 0 005/078 1 SUPREME COURT OF THE STATE OF NEW YORK 1 2 COUNTY OF NIAGARA 3 2 3 44 5 fN RE; NEW YORK CITY 8 ASBESTOS LITIGATION 7 5 6 7 88 9 DEPOSITION 9 10 UNDER ORAL 10 -!
refid# Dd8jB3a50yYKk4XzB5kvNqb7N74 pages
received OPPT HCIC ^ HAY200 i 2 4i1 9: j q ^ Study Title T e n n e s s e e R iv e r V a ll e y S a m p le s 26" 1733 Author Mark E.
refid# zd9mrpMG43zyv8M4z9aGLnYaz276 pages
FINAL REPORT ONE GENERATION REPRODUCTION STUDY OF PFOS - MEVALONIC ACID/CHOLESTEROL CHALLENGE AND NOEL INVESTIGATION IN RATS SPONSOR'S STUDY NUMBER: T-6295.25 FINAL REPORT DATE: 16 DECEMBER 2002 TITLE - ONE GENERATION REPRODUCTION STUDY OF PFOS - MEVALONIC ACIDKHOLESTEROL CHALLENGE AND NOEL INVESTIGATION IN RATS ARGUS STUDY NUMBER: 4 18-018 SPONSOR'S STUDY NUMBER: T-6295.25 TABLE OF CONTENTS SUBJECT PAGE I.
refid# qde2XX89mkxKmp7M4K4ZdEnaE1,087 pages
FINAL REPORT PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 31 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.
refid# nmgjr9740RzvQpEmDDYB7qEr8769 pages
A f i S.&6 - i S 06 90S Sheehy Drive, Bldg.
refid# qkVj9Ry6OdjZGKZQpngznq7OR1,088 pages
AR226-1523 FINAL REPORT RECEIVED OPPT NClC 03 SEP 30 PM1:OO PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTALTOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 3 1 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTIONLDEVELOPMENTAL TOXICITY SCREENINGTEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.
refid# Rpk00B3Mgpy4vN4BxxY3LaKg7769 pages
AR226-1523 FINAL REPORT RECEIVED OPPT NCIC 03 SEP 30 PM1:00 PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 31 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENINGTEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.
refid# oDEL11ZE9J3Y6LodJ4grwN6Er769 pages
FINAL REPORT PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 31 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.
refid# ym96DEGdwaQ0pKd0MNMNnkJMV769 pages
RECiiiVEO O P P NC IC 200*4MAY 12 AH 9= 10 -4&224r mo FINAL REPORT PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 31 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.
refid# oD81D3yjGQBBnrMJz7a38Yr771 pages